NeurosciencebioRxivPreprint
Agomelatine drives sex-specific neuroprotection and reduced pathology in rat and human Alzheimer's models
Grace Terry, Siaresh Aziz, Nishat Raihana…·Maria E. Figueiredo-Pereira
This paper identifies agomelatine as a disease-modifying candidate for Alzheimer's disease, showing sex-specific neuroprotection and reduced pathology in both rat and human models.